Table 4.
Variables | Baseline (Mean ± SD) | 3 Months (Mean ± SD) | 6MWT Overtime | Intubation Status (Covariate)** |
---|---|---|---|---|
N = 100 | N= 76 | p value | p value | |
Initial heart rate, b/m | 84.28 ± 12.41 | 78.93 ± 12.2 | < 0.001 | 0.417 |
Final heart rate, b/m | 107.28 ± 17.00 | 104.85 ± 15.34 | 0.160 | 0.316 |
Δ Heart rate reduced by at 1 min | 17.26 ± 11.07 | 19.16 ± 10.57 | 0.161 | 0.871 |
Heart rate 1 min post 6MWT, b/m | 89.95 ± 13.34 | 84.99 ± 13.04 | < 0.001 | 0.416 |
Initial Borg Dyspnea score | 1.35 ± 0.48 | 1.09 ± 0.30 | < 0.001 | 0.429 |
Final Borg Dyspnea score | 2.47 ± 0.90 | 2.11 ± 0.59 | < 0.001 | 0.427 |
Initial Borg Fatigue score | 1.23 ± 0.46 | 1.07 ± 0.30 | 0.013 | 0.598 |
Final Borg Fatigue score | 1.77 ± 0.75 | 1.41 ± 0.62 | < 0.001 | 0.468 |
Initial SpO2, % | 96.76 ± 1.86 | 97.84 ± 1.07 | < 0.001 | 0.747 |
Lowest SpO2, % | 93.7 ± 5.0 | 96.3 ± 2.0 | < 0.001 | 0.772 |
ΔSpO2 | 3.01 ± 3.69 | 1.44 ± 1.85 | < 0.001* | 0.820 |
Δ SpO2 1 min post 6MWT, % | 96.28 ± 4.58 | 97.92 ± 0.17 | 0.003 | 0.660 |
6MWD, m | 386.50 ± 78.45 | 437.22 ± 58.91 | < 0.001 | 0.631 |
Notes: *Wilcoxon test was used due to skewed distribution. **General Linear Model (GLM) was used. All significant p values in bold text.